PortaCellTec biosciences GmbH

OATP1B1 (SLCO1B1)

Molecular structure and tissue distribution
OATP1B1 (previously known as OATP-C) is highly expressed in liver where it is localized to the basolateral membrane of the hepatocytes. The gene for OATP1B1 is located on chromosome 12p12. The two hepatocyte-specific OATPs OATP1B1 and OATP1B3 seem to have no orthologous proteins in mouse or rat. Therefore, the transferability of animal data to humans is difficult with regard to OATPs.


Interaction of OATP1B1 with endogenous compounds and drugs

OATP1B1 mediates the uptake of many different drugs from blood into hepatocytes. Endogenous compounds that are transported by OATP1B1 are bile salts like taurocholate but also estrone sulfate and sulfobromophthalein (BSP) which are used as model substrates.
Drug substrates of OATP1B1 are e.g. statins (pravastatin, rosuvastatin), antibiotics (rifampicin, benzylpenicillin) and cytostatics (methotrexate). For some drugs it seems that a genetic variation (521T>C; V174A) is associated with an altered pharmacokinetic.


Figure 1 Time dependency experiments with estrone-3-sulfate Figure 2 Inhibition of OATP substrates by rifampicin.

 

PortaCellTec

News

New validated products:

  • MRP2
  • roct1

Events

2nd German Pharm-Tox Summit
Heidelberg, Germany
March 06-09, 2017

19th Barrier- and
Transporter-Meeting

Bad Herrenalb, Germany
May 15-17, 2017

14th European ISSX Meeting
Köln, Germany

June 26- 29, 2017

2nd Symposium on Transporters in Drug Discovery
London, UK
May 15-16, 2017



Münster Transporttage 2017
Münster, Germany
October 21 – 22, 2017

 


Guidance for Industry (FDA and EMA)

Publications